SUMMARY OF RESEARCH - NASA · (HP cross-links), and lysylpyridinoline (LP cross-links) were assayed...
Transcript of SUMMARY OF RESEARCH - NASA · (HP cross-links), and lysylpyridinoline (LP cross-links) were assayed...
GRANT NUMBER:
SUMMARY OF RESEARCH
NAG-2-1089
GRANT TITLE: An Evaluation of Collagen Metabolism in Non Human PrimatesAssociated with the Bion 11 Space Program-Markers of UrinaryCollagen Turnover and Muscle Connective Tissue.
PRINCIPAL INVESTIGATOR: Arthur C. Vailas, Ph.D.
Vice Chancellor for Research and Intellectual PropertyManagement, UH Systems, Vice President for Research,University of HoustonCo-Director, Connective Tissue Research LaboratoryTe1:713-743-9104Fax:713-743-9125Email: [email protected]
INSTITUTION: UNIVERSITY OF HOUSTON4800 Calhoun Blvd
Houston, Texas 77204-2162
PERIOD OF REPORT: 07/01/96 TO02/28/99
https://ntrs.nasa.gov/search.jsp?R=19990047442 2020-07-02T01:45:09+00:00Z
AN EVALUATION OF COLLAGEN METABOLISM IN NON
HUMAN PRIMATES ASSOCIATED WITH THE BION 11 SPACE
PROGRAM-MARKERS OF URINARY COLLAGEN TURNOVER AND
MUSCLE CONNECTIVE TISSUE.
Principal Investigator:
Co-Principal Investigator:
Technical Monitor:
NASA-Ames Grant Officer:
Arthur C. Vailas, Ph.D.
Vice Chancellor for Research and Intellectual Property Management,UH Systems, Vice President for Research, University of HoustonCo-Director, Connective Tissue Research Laboratory4800 Calhoun Blvd
E. Cullen BuildingUniversity of HoustonHouston, Texas 77204-2162Te1:713-743-9104Fax:713-743-9125Email: [email protected]
Daniel A. Martinez, Ph.D.
Research Assistant Professor, Department of Biochemistry andBiology, Division of Molecular and Cellular BiologyCo-Director, Connective Tissue Research LaboratoryUniversity of HoustonHouston, Texas 77204-5513Tel: 713-743-2662Fax: 713-743-2636Email: [email protected]
Richard E. Grindeland, Ph.D.
Chief Scientist Bion ProgramNASA-Ames Research Center
Moffett Field, CA 94035- I000Tel: 415-604-5756
Beatrice Morales
University Affairs Grants OfficeNASA-Ames Research CenterBranch 241-1
Moffett Field, CA 94035-1000Tel: 650-604-5811
UH-Research Admin.: Barbara DeHaven, Interim Director
Office of Sponsored ProgramsRm 316, E. Cullen BuildingUniversity of HoustonHouston, Texas 77204-2162Tel: 713-743-9201Fax: 713-743-9227
BION 11 FINAL REPORT
UNIVERSITY OF HOUSTONCONNECTIVE TISSUE
PHYSIOLOGY LABORTORY
3
TABLE OF CONTENTS
INTRODUCTION....................................................................................................... 5
METHODS ............................................................................................................ 5
RESULTS ............................................................................................................. 6
SUMMARY FINDINGS ................................................................................................ 7
TABLES ............................................................................................................... 9
Pre-Flight and Post-Flight Urine BiomarkerAnalyses (Normalized to Creatinine) .................... 10Pre-Flight and Post-Flight Urine BiomarkerAnalyses (Non-normalized to Creatinine) ............... 11Urinary Calcium and Osteocalcin Pre-Flight and Post-Flight Analyses ................................. 12Soleus Pre-Flight and Post-Flight Biopsies Muscle Connective Tissue Analyses ..................... 13Tibialis Anterior Pre-Flight and Post-Flight Biopsies Muscle Connective Tissue Analyses .......... 14Medial Gastrocnemius Pre-Flight and Post-Flight Biopsies Muscle Connective Tissue Analyses... 15
FIGURES ............................................................................................................. 16
Urinary Hyp and Hyp/Cr Pre-Flight & Post-Flight Values ............................................... 17Urinary HP and HP/Cr Pre-Flight & Post-Flight Values ................................................. 18Urinary LP and LP/Cr Pre-Flight & Post-Flight Values .................................................. 19Urinary Total Collagen Cross-links Pre-Flight and Post-Flight Values ................................. 20Urinary Creatinine Pre-Flight and Post-Flight Values ..................................................... 21Monthly Hyp Values .......................................................................................... 22Monthly Hyp/Cr Values ....................................................................................... 23Monthly HP Values ............................................................................................ 24Monthly HP/Cr Values ........................................................................................ 25Monthly LP Values ............................................................................................ 26Monthly LP/Cr Values ........................................................................................ 27Monthly Total Cross-links (HP+LP/Cr) Values ........................................................... 28Monthly Creatinine Values .................................................................................... 29Daily Hyp Values .............................................................................................. 30Daily Hyp/Cr Values .......................................................................................... 31Daily HP Values ............................................................................................... 32Daily HP/Cr Values ............................................................................................ 33Daily LP Values ................................................................................................ 34
Daily LP/Cr Values ............................................................................................ 35Daily Total Cross-links (HP+LP/Cr) Values ............................................................... 36Daily Creatinine Values ....................................................................................... 37
4
INTRODUCTION
Patientsexhibitingchangesin connectivetissueandbonemetabolismalsoshowchangesin urinary
by-productsof tissuemetabolism. Furthermore,the changesin urinary connectivetissueand bone
metabolitesprecedealterationsat thetissuemacromolecularlevel. Astronautsand Cosmonautshave
also shown suggestiveincreasesin urinary by-productsof mineralizedand non-mineralizedtissue
degradation.Thus,the ideaof assessingconnectivetissueandboneresponsein spaceflightmonkeys
by measurementof biomarkersin urine has merit. Other investigationsof bone and connective
histology,cytology andchemistryin the Bion 11 monkeyswill allow for further validationof the
relationshipof urinarybiomarkersandtissueresponse.In futureflights thenon-invasiveprocedureof
urinaryanalysismaybeusefulin earlydetectionof changesin thesetissues.Purpose." The purpose of
this grant investigation was to evaluate mineralized and non-mineralized connective tissue responses of
non-human primates to microgravity by the non-invasive analysis of urinary biomarkers. Secondly,
we also wanted to assess muscle connective tissue adaptive changes in three weight-bearing skeletal
muscles: the soleus, medial gastrocnemius and tibialis anterior by obtaining pre-flight and post-flight
small biopsy specimens in collaboration with Dr. V. Reggie Edgerton's laboratory at the University of
California at Los Angeles.
METHODS
Twenty-four hour samples were obtained intermittently before flight and after flight, before and
after 1 G simulations of flight, and from vivarium monkeys. Urine volumes were measured and
aliquots were frozen for subsequent analysis.
Collagen biomarker concentrations of urinary hydroxyproline (Hyp), hydroxylysylpyridinoline
(HP cross-links), and lysylpyridinoline (LP cross-links) were assayed by reverse-phase high
performance liquid chromatography (RP-HPLC).
Urinary creatinine (Cr) was quantitated using a colorimetric assay to measure potential muscle
rhabdomyolysis and to normalize the connective tissue and bone mineral bio-marker concentrations.
Bonemineralmetabolismwasanalyzedbyassayingpre-andpost-flight urinary calcium(Ca 2÷) by
atomic absorption. Urinary osteocalcin (Oc), a biomarker for bone formation was analyzed by
immunoassay with a polyclonal antibody raised against bovine Oc with tracer and standards derived
from purified Macaca mulatta bone Oc.
Skeletal muscle hydroxyproline, an index of collagen concentration, and the mature collagen cross-
links (HP and LP) were measured on micro-biopsy specimens from the pre-flight and post-flight time
periods from all three groups.
Statistics: The urine measurements were analyzed using a two factorial repeated measures analyses
of variance (ANOVA) with the significance set at P<0.05.
RESULTS
Collagen Biomarkers: Summary Tables (Pre-Flight and Post-Flight) and Graphs (Pre-Post,
Monthly and Daily Analyses) can be found in the appropriate sections.
Results indicate a high daily variance in the urine concentration of collagen metabolic biomarkers.
The urinary collagen cross-link content in the postflight urines were significantly greater (P<0.05) in
the Flight group compared to the Simulation and Vivarium groups indicating that more mature collagen
had been degraded during the initial postflight recovery period in the Flight group. Creatinine analyses
showed that in all groups urinary levels were significantly elevated (92%-111%) from preflight and the
urinary content of non-reducible collagen cross-links (nM HP+LP/mM Cr) were overall greater during
the postflight period (21%-35%).
Bone metabolism." Urinary Ca 2÷ measures were significantly lower (Flight -72%, Simulation
-57%, Vivarium-31%) after flight versus preflight measurements (P<0.05). Oc analyses indicated
that Flight (-43%) and Vivarium (-32%) had significantly lower Oc values postflight.
Muscle Connective Tissue." In the soleus muscle, the only significant changes observed were in the
Vivarium group. The Hyp values were significantly greater post-flight versus preflight values
(P<0.05). There was a trend towards decreased LP values post-flight compared to pre-flight values
6
(P<0.09). No significantchangeswere found in the Flight or Simulatedsoleusmuscleconnective
measurements.In thetibialis anterior,theonly significantdifferenceswerefound in theFlight group.
Post-flightHyp wassignificantlysmallerin the Flight group in contrastto pre-flight measurements
(P<0.05). However,HP andTotal Cross-linkmeasurements(HP+LP) tendedto be largerpost-flight
comparedto preflight measurements(HP: P<0.07) and (HP+LP: P<0.09) respectively. The medial
gastrocnemius muscle demonstrated no significant differences in any measurements post-flight versus
preflight (P>0.05)
SUMMARY FINDINGS
. Biomarker profiles can be used as a first level non-invasive analyses to determine if connective
tissue metabolism has been altered following spaceflight. Initial postflight measurements of
collagen and mineral biomarkers, demonstrated in the first days following flight in the Daily
Graphs, suggest an increase in mineralized and non-mineralized connective tissue turnover in the
Flight group.
. Elevated urine Hyp, HP+LP cross-link levels together with reduced urine Ca 2÷ levels may indicate
new collagen secretion and Ca 2÷ storage, signifying new bone formation during postflight
recovery.
. Biomarker analyses investigating the temporal transitions of whole body collagen and mineral
metabolism would be greatly enhanced if future experiments facilitated daily in-flight sample
collection of urine from the primates aboard the unmanned space habitat.
. Overall, no dramatic muscle connective tissue changes were observed post-flight in the SOL, MG
or TA muscles. However, there was a significant decrease in skeletal muscle collagen in the post-
flight TA biopsies in the Flight group with an accompanying increase in muscle collagen cross-
.
,
linking suggesting that the interstitial collagen is older "more mature" collagen. This findings were
not observed in the SOL or MG muscle biopsies.
Fourteen days exposure to microgravity may not have been an adequate interval of time to view
changes in skeletal muscle connective tissue protein. However, changes at the molecular level of
collagen synthesis (measures of mRNA for COL 1A1, COL 3A1 and Lysyl Oxidase) may be
evident when analyzed.
The biopsy samples received from Dr. Reggie Edgerton's laboratory were smaller in mass than
what our current molecular biology methodology could quantitate. If our Laboratory receives
further funding, we will attempt to optimize our mRNA assays for less than ~0.5-2.0 mg tissue
wet weight.
w
8
TABLES
9
<
°D 0 _
_ ._ _
_ o_ Z
!
Ill
_o
÷1
_o
÷1
+1
+1
oo
oJ1 q_"
11
oo
+1
+1
Lr_
+1
+1
t_
+1
_o
÷1
%
+1Q_
_o
÷1
+1
imq
t_
÷1Q_
+l
÷1r_
t_
+1
t_
+1
_o
+1
Q_
÷1
u_
÷1
c_+1
+1
_0oJ_
_L__ _._
_.} ..
_,} v c1_ v
J_
m
_N
{l'}
+1c_
r_
t,...l
B©
° '_,,,,--I
I
©
'P,---,4
I
<_
°v-,4
°+,--,4
<_
O
N,, +,--I
B©
I
©
Z
:::It.
•,_ t_
O
"H 4"It'_
t'_
-I-I<_ 4-I
,-+4-I -H
i_ ,-_
_ ,+..+___.+
t_
-H
3
I"I
4-It_
4-It_
-I-I+--4
e+"l
4-I
,,-,,-,4
-I-I
4"I
t_
v
Ot_
_i t,,_ _+'_
4"I 4"I
_ m+1 +1
o _
+1 +1
m _
m _
C',l
4"1 -H
m ./
++ +
+1
o_
rj©
©
oI=.N
r._
<
I
©
._==_
I
.m
o..¢
_0
-I-
r._
i,
%.r-i
÷I
+I e_
.m
0
+I
÷I _'_+I
oJ_
+I _'_
4-I +I _'_
{",I
¢_.
I
om
I=.
t",l
oJ1 L_ H
_ l_
c_
_J
_v
÷l t_J_
ocs_
P_ O0 Nq
o
°_ _ _ _
0 --qd _
_ o
÷I ÷I
• ÷I ÷I
r_
i i
_°V
_÷
L_
._
f_
c_
_o
o
im_ 0
0
J_m_ H
Lf_
FIGURES
16
=_|_ = ; =--,=--,
omm
u m u u n0 0 0 0 0 0
-)
0
(,'[oxlIDm)
$1111
.... I " " " I " " " I • " " I
o o _ _ ° o
o0
n
o
omm
[[o]m'mllO_) _3/d'l[
0
i i ...m--_
I.i +)+)omm
m • • • m • • • m0 0 0 0
0 m 0
C_) or[
,''m"
0m
0
1_ m
I
omm
_-4 m i m0 om 0 0 0O0 (D _ ¢_ 0
([o]D,(ml[o:]_Iz) _::)Id'l[+d:l.]
IIIo
-)
0O0
0
I.a
olPml
I.=1
_mm- v
onn
i-I mnO----e
m U m
1=4
!
Q0
G
_o
f
/,6-_]N
/.6-qo_[
!/.6-treJ[' _
_-:_,o_
96-dos
96-_nv
96-1nr
96 -unj[,
Ol "4 I,.4
(,lm/_m) ,u_
0
0
4-)
I-,
0
I
0I
0I
0CI
I
0
/,6-;m]ff
&6-qa_[
4,
- 96-_;)0
o
96-das
,96-_nv
- 96-1nr
96 -un_o
0
(,_
.la
1,4
W
eel
/.6-_H
,/.6-qo_[
&6-fret
96-1=0
96-dos
96-Jnv
96-unr
000t_
00
v..4
00
0
I
I I ' I
Q @ 0O m O
(]/_ul]r_-u)_::)Id._
,96-_nv
96-1nr
96 -unf.
0
ep,q
0 0 0 0 0 00 _ 0 m 0 m
(/Alu) d'I
0
/.6-_]N
,/.,6-qa_[
/'6"uw-° i
4,
,96-das
96-_nV
96-[n_P
96-unp
t.,
0
0 0 0 0 0
_=I]_) _]ol a'[
/,6-_]N
/.6-qo_l
96-:to0
,96-dos
96-JnV
,96-1nr
96-unr
0
&6-xe]N
m
1.4
.om
OL_01
00e_
0
tINm/Mu) _lOlcl'l+(ll-I
00,..¢
0
&6-qo_
4
&6-zref'_
!_B-1,o0
96-des
96-JuV
96-1uf'
96-unr
I-,
m
ee=l
.ka
I
.,q
II
0
(]Rm) _u_;_goz:)
I
-/.6-_e]N
/.6-qo_[
,96-des
96-]ilnV
,96-1nr
96-unr
0
I=i 6101
'_I01
L_16
w._ g'¢16
6116
LXI6
'_116
)I16
'_ I,/6
919
glp.
g'g19
0 0 0 0 0
(-[ml_)
0
@
I=,
C)
w
::==:,.--e
I
I
0 0 0 0 0 0
(wmlJm) _:)/aJ_
,v_Iz
o'_I_
sxl_
9zl_
, _xl_
9-_Ix
g_l[
[_I'[
6[Ix
, t..xl[
II/I
611
LII
1,/OI
_/ox
t.._/6
61116
. LxI6
_I16
01116
916
I,/6
' S18
_Is
gl/-
8Z19
0
m
l.e
m
I)
m__._.===
o 0o 00 0
I
o00I-i
/G
fl'Mt
9"_/I
611t
P-III
,_11X
X11T
6/0I
_/0I
_/0I
L_I6
sx/6
o1/6
9/6
t,/6
s/s
9/8
' _18
0
0
_1 I I
9zl_
_xl_
_xl_
6"_It
9_/x
x_Ix
,6xlx
_' g'¢16
61160
t.xl6_X/6
o116
,916
=|=
0 0 0 0 0 0 0
(.wmlwu) ao/aH
g16
919
8_19
0
l.q
I
oo00
I
I-
I
I
00cD
I
00
(]4t_x) d_l
I
0o
m
i
I
0 0 0 0 0 0
(wml_u) _ola'x
gxlg
0_I_
,g11_
_xl_
g'_/!
9"_Ix
g_Ix
X_Ix
611X
,t._Ix
'till
p.lx
610X
'_I0;
_/6
61/6
LII6
ZXI6
oil6
916
'I'/6
9/g
g/i.
g'_/9
0
Cr_
bl
C,)
"I"
I
0o
i
I
ooc_
I
I
00
twmlHu) _lolo'_[+d'l'X
ooIll
I_I_
0"¢I_
,g[l_
- ox/_
- _x/_
_iII:
s"_ll
_'_I[
[_Ix
'6'[11
"t..'[Ix
- _x/x
xx/1
- 611
: L/x
I.- g_16
6116
t.xl6
_I_16
01[16
916
' II,16
- 916
918
_18
glP-
8"_19
0
O_
G
W
D,
0
I
oI
o
I
I
0cq
O,.d
0
9l/Z
p11c
CTI_
9"_II
9"_II
,c_l]
TclT
t.'t/'lt
_,'t/'t
TTIT
61T
LIT
plot
Z:IOT
/..El6
_16
6116
,/..,116
9/6
I,/6
S/S
9/9
' Z/9
9Z/9
[-..cr_